Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03756480 · ClinicalTrials.gov registry record

Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance

A clinical trial of Endometriosis and Endometrial Diseases, sponsored by Johns Hopkins University.

Active
Registry status
135
Enrollment target
3
Study locations

NCT03756480 is a study of Endometriosis and Endometrial Diseases that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 135 participants, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (48% lower). The trial reports 3 study locations across 3 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03756480, a study of Endometriosis and Endometrial Diseases, is active but no longer recruiting, sponsored by Johns Hopkins University.

ACTIVE NOT RECRUITING
Registry status
135 participants
Enrollment target
3
Study locations

Study Summary

This study will test the hypothesis that the molecular changes present in ectopic endometriosis lesions correlate with progesterone-resistant disease (using the criteria defined in this study) and are present in matched eutopic endometrium.

Study Locations (3)

Connecticut

  • Yale School of Medicine - New Haven

Maryland

  • Johns Hopkins Hospital - Baltimore

Tennessee

  • Vanderbilt University Medical Center - Nashville

Trial Details

FieldValue
Enrollment Target 135 participants
Start Date 2020-10-01
Est. Completion 2026-10-01

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03756480

The ClinicalTrials.gov registry entry for NCT03756480 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 135 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 261-participant average among 48 other Endometriosis trials with a reported enrollment target (48% lower). The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Endometriosis appearing as the primary indexed condition, and to 0 interventions.

NCT03756480 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Connecticut, Maryland, Tennessee.

Frequently Asked Questions

What is clinical trial NCT03756480 about?

NCT03756480 is a clinical study titled "Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance". This study will test the hypothesis that the molecular changes present in ectopic endometriosis lesions correlate with progesterone-resistant disease (using the criteria defined in this study) and are present in matched eutopic endometrium.

What is the current status of trial NCT03756480?

This trial is currently active not recruiting. The enrollment target is 135 participants. The study started on 2020-10-01. Estimated completion is 2026-10-01.

What conditions does trial NCT03756480 study?

This clinical trial studies the following conditions: Endometriosis, Endometrial Diseases.

Who is sponsoring clinical trial NCT03756480?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03756480 being conducted?

This trial has 3 study locations across Connecticut, Maryland, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Endometriosis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.